Table 2.
Pathological response assessment by radiological response group
Complete response MRI (n = 136) | Partial response MRI (n = 31) | Total (n = 167) | |
---|---|---|---|
Pathological response surgical specimen | |||
No residual carcinoma (1i) | 81 (60%) | 8 (26%) | 89 (53%) |
No residual invasive but DCIS (1ii) | 8 (6%) | 0 | 8 (5%) |
Minimal residual disease, < 10% (2i) | 31 (23%) | 8 (25%) | 39 (23%) |
10-50% of tumor remaining (2ii) | 11 (8%) | 12 (39%) | 23 (14%) |
>50% of tumor remaining (2iii) | 3 (2%) | 3 (10%) | 6 (4%) |
No evidence of response (3) | 1 (1%) | 0 | 1 (1%) |
Only LVSI present | 1 (1%) | 0 | 1 (1%) |
Pathological response biopsies | |||
Tumor-negative | 107 (79%) | 11 (35%) | 118 (71%) |
Tumor-positive | 29 (21%) | 20 (65%) | 49 (29%) |
Data are n (%). LVSI, lymphovascular invasion